Global Smart Insulin Pen Market
Market Size in USD Billion
CAGR :
%

![]() |
2022 –2029 |
![]() |
USD 31.20 Million |
![]() |
USD 62.63 Million |
![]() |
|
![]() |
|
Global Smart Insulin Pen Market, By Product (Smart Insulin Pens, Adaptors for Conventional Pens, Disposable, Reusable), Type (First Generation Pens, Second Generation Pens), Usability (Prefilled, Reusable), Connectivity Type (Bluetooth, USB), Application (Type 1 Diabetes, Type 2 Diabetes), Distribution Channel (Hospital Pharmacies, Online Sales, Retail Pharmacies, Diabetes Clinics / Centers) – Industry Trends and Forecast to 2029
Smart Insulin Pen Market Analysis and Size
This smart insulin pen calculates and tracks doses and provides helpful reminders, alerts, and reports. The smart insulin pens also come with extra functions including data transfer, time and dose recorder, and memory function. In the coming years, a crucial aspect that is anticipated to propel the global market for smart insulin pen is the rise in prevalence of the two forms of diabetes in both children and adults, which is caused by obesity and changing lifestyle and dietary habits.
Data Bridge Market Research analyses that the smart insulin pen market which was USD 31.2 million in 2021, would rocket up to USD 62.63 million by 2029, and is expected to undergo a CAGR of 9.10% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
Report Metric |
Details |
Forecast Period |
2022 to 2029 |
Base Year |
2021 |
Historic Years |
2020 (Customizable to 2014 - 2019) |
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
Segments Covered |
Product (Smart Insulin Pens, Adaptors for Conventional Pens, Disposable, Reusable), Type (First Generation Pens, Second Generation Pens), Usability (Prefilled, Reusable) Connectivity Type (Bluetooth, USB), Application (Type 1 Diabetes, Type 2 Diabetes), Distribution Channel (Hospital Pharmacies, Online Sales, Retail Pharmacies, Diabetes Clinics / Centers) |
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered |
Emperra GmbH E-Health Technologies (Germany), Medtronic (Ireland), Novo Nordisk A/S (Denmark), Pendiq (Germany), Sanofi (France), Berlin-Chemie AG (Germany), Bigfoot Biomedical Inc. (U.S.), Digital Medics Pty Ltd. (Australia), Eli Lilly and Company (U.S.) |
Market Opportunities |
|
Market Definition
Smart insulin pens are reusable injector pens that can be connected to smartphone apps. The majority of diabetic patients face difficulty to calculate their insulin dosage. The result could be insulin stacking. It helps you to improve insulin administration by managing your diabetes. These "second-generation" pens pair with USB or Bluetooth technology to enable wireless transmission of data to your app.
Global Smart Insulin Pen Market Dynamics
Drivers
- Technological advancements
Emerging technologies in smart insulin pens are projected to drive the global smart insulin pen market during the forecast period. To detect the insulin level, an iSenz adaptor is used for smart insulin pens. It offers injection angles for diabetic injection site optimization. For insulin pens connected to the internet, there is an adaptor called Easylog. In order to manage chronic illnesses such as diabetes, it gives patient the proper dosage and delivers improved comfort. InsulCheck is a cap that fits insulin pens and has a sensor to monitor temperature and consumption. And these are some of the examples of smart insulin pens which accelerate the market growth.
- Integration of monitoring and therapeutic features
Smart insulin pens have many benefits for diabetes management. These pens have extra features that make it easier to keep track of the previous insulin dose. Daily injections of insulin with a syringe and needle are challenging and unpleasant. With improvements in device communication technology, more people are using their smartphones and the internet to track their records and drives the market's growth.
Opportunities
Integrated technology measuring blood glucose levels and determining insulin dosage. Patients can provide their information to doctors or other healthcare experts through sophisticated technological tools and apps. For instance, In pen insulin pens are linked to smartwatches, armbands, and smart apps, which assist in tracking physical activity and transmitting the information to doctors. The US market has seen increased competition from a number of manufacturers. For instance, Novo Nordisk's NovoPen® 6 and NovoPen Echo® Plus, which can record and save the past 800 injection doses, including airshots, and enable optimal insulin management, were approved for use in 2019.
Restraints/Challenges
- Increased adoption of refurbished systems
On the other hand, the high cost of insulin pens, poor reimbursement rates will obstruct the market's growth rate. It's common for refurbished systems to cost less than brand-new ones. For industry participants, particularly small manufacturers, the rising demand for refurbished products poses a significant challenge.
This smart insulin pen market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the smart insulin pen market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In February 2020, A partnership between Senseonics and Companion Medical was announced. Senseonics is a US-based medical technology firm that primarily focuses on designing, developing, and marketing glucose monitoring systems. The relationship will benefit both businesses by fusing the Eversense CGM Technology with the InPenT smart system for precise insulin delivery.
- In March 2022, Novo Nordisk announced the Novo Pen 6 and Novo Pen Echo Plus, two smart linked insulin pens that are currently available in the UK on prescription for those with diabetes who use Novo Nordisk insulin. These two new smart insulin pens, the Novo Pen 6 and Novo Pen Echo Plus, record each injection's insulin dosage automatically.
Global Smart Insulin Pen Market Scope
The smart insulin pen market is segmented on the basis of usability, product type, connectivity type, application and distribution-channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Usability
- Prefilled
- Reusable
Product
- Smart Insulin Pens
- Adaptors for Conventional Pens
- Disposable
- Reusable
Connectivity Type
- Bluetooth
- USB
Application
- Type 1 Diabetes
- Type 2 Diabetes
Distribution Channel
- Hospital Pharmacies
- Online Sales
- Retail Pharmacies
- Diabetes Clinics / Centers
Smart Insulin Pen Market Regional Analysis/Insights
The smart insulin pen market is analysed and market size insights and trends are provided by country, product type, connectivity type, application and distribution-channel as referenced above.
The countries covered in the smart insulin pen market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the smart insulin pen market due to rise in prevalence of diabetes, new product launches and high cost of smart insulin pen are also expected to contribute to the regional market growth.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the increase in geriatric population with diabetes in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The smart insulin pen market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for smart insulin pen market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the smart insulin pen market. The data is available for historic period 2010-2020.
Competitive Landscape and Smart Insulin Pen Market Share Analysis
The smart insulin pen market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to smart insulin pen market.
Some of the major players operating in the smart insulin pen market are:
- Emperra GmbH E-Health Technologies (Germany)
- Medtronic (Ireland)
- Novo Nordisk A/S (Denmark)
- Pendiq (Germany)
- Sanofi (France)
- Berlin-Chemie AG (Germany)
- Bigfoot Biomedical Inc. (U.S.)
- Digital Medics Pty Ltd. (Australia)
- Eli Lilly and Company (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1.INTRODUCTION
1.1OBJECTIVES OF THE STUDY
1.2MARKET DEFINITION
1.3OVERVIEW OF GLOBAL SMART INSULIN PEN MARKET
1.4CURRENCY AND PRICING
1.5LIMITATION
1.6MARKETS COVERED
2.MARKET
2.1KEY TAKEAWAYS
2.2ARRIVING AT THE GLOBAL SMART INSULIN PEN MARKET SIZE
2.2.1VENDOR POSITIONING GRID
2.2.2TECHNOLOGY LIFE LINE CURVE
2.2.3TRIPOD DATA VALIDATION MODEL
2.2.4MARKET GUIDE
2.2.5MULTIVARIATE MODELLING
2.2.6TOP TO BOTTOM ANALYSIS
2.2.7CHALLENGE MATRIX
2.2.8APPLICATION COVERAGE GRID
2.2.9STANDARDS OF MEASUREMENT
2.2.10VENDOR SHARE ANALYSIS
2.2.11EPIDEMIOLOGY
2.2.12DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13DATA POINTS FROM KEY SECONDARY DATABASES
2.3GLOBAL SMART INSULIN PEN MARKET: RESEARCH SNAPSHOT
2.4ASSUMPTIONS
3.MARKET OVERVIEW
3.1DRIVERS
3.2RESTRAINTS
3.3OPPORTUNITIES
3.4CHALLENGES
4.EXECUTIVE SUMMARY
5.PREMIUM INSIGHTS
6.EPIDEMIOLOGY
6.1INCIDENCE OF ALL BY GENDER
6.2TREATMENT RATE
6.3MORTALITY RATE
6.4DRUG ADHERENCE AND THERAPY SWITCH MODEL
6.5PATEINT TREATMENT SUCCESS RATES
7.INDUSTRY INSIGHTS
7.1PATENT ANALYSIS
7.2DRUG TREATMENT RATE BY MATURED MARKETS
7.3DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES
7.4PATIENT FLOW DIAGRAM
7.5KEY PRICING STRATEGIES
7.6KEY PATIENT ENROLLMENT STRATEGIES
7.7INTERVIEWS WITH CARDIOLOGIST
7.8OTHER KOL SNAPSHOTS
8.REGULATORY SCENARIO
9.PIPELINE ANALYSIS
9.1PHASE III CANDIDATES
9.2PHASE II CANDIDATES
9.3PHASE I CANDIDATES
9.4OTHERS (PRE-CLINICAL AND RESEARCH)
10.GLOBAL SMART INSULIN PEN MARKET, BY PRODUCT TYPE
10.1OVERVIEW
10.2INTEGRATED SMART INSULIN PENS
10.3ADAPTORS FOR CONVETIONAL PENS
10.3.1REUSABLE
10.3.2DISPOSABLE
10.4OTHERS
11.GLOBAL SMART INSULIN PEN MARKET, BY USABILITY
11.1OVERVIEW
11.2PREFILLED
11.3REUSABLE
12.GLOBAL SMART INSULIN PEN MARKET, BY TYPE
12.1OVERVIEW
12.2FIRST GENERATION PENS
12.3SECOND GENERATION PENS
13.GLOBAL SMART INSULIN PEN MARKET, BY CONNECTIVITY
13.1OVERVIEW
13.2BLUETOOTH
13.2.1BY COMPATIBILITY
13.2.1.1.ANDROID
13.2.1.2.IOS
13.2.2BY BRAND
13.2.2.1.INPEN
13.2.2.2.VIGIPEN
13.2.2.3.ESYSTA
13.2.2.4.YPSOMATE SMARTPILOT
13.2.2.5.OTHERS
13.3USB
13.3.1BY COMPATIBILITY
13.3.1.1.ANDROID
13.3.1.2.IOS
13.3.2BY BRAND
13.3.2.1.PENDIQ 2.0
13.3.2.2.OTHERS
13.4NFC
13.4.1BY COMPATIBILITY
13.4.1.1.ANDROID
13.4.1.2.IOS
13.4.2BY BRAND
13.4.2.1.NOVOPEN 6
13.4.2.2.NOVOPEN ECHO
13.4.2.3.OTHERS
13.5OTHERS
14.GLOBAL SMART INSULIN PEN MARKET, BY DISEASE TYPE
14.1OVERVIEW
14.2TYPE 1 DIABETES
14.2.1PREFILLED
14.2.2REUSABLE
14.3TYPE 2 DIABETES
14.3.1PREFILLED
14.3.2REUSABLE
15.GLOBAL SMART INSULIN PEN MARKET, BY END USER
15.1OVERVIEW
15.2HOSPITAL
15.3SPECIALITY CLINICS
15.4HOME HEALTHCARE
15.5OTHERS
16.GLOBAL SMART INSULIN PEN MARKET, BY DISTRIBUTION CHANNEL
16.1OVERVIEW
16.2HOSPITAL PHARMACY
16.3RETAIL PHARMACY
16.4ONLINE PHARMACY
16.5OTHERS
17.GLOBAL SMART INSULIN PEN MARKET, BY GEOGRAPHY
17.1GLOBAL SMART INSULIN PEN MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
17.1.1NORTH AMERICA
17.1.1.1.U.S.
17.1.1.2.CANADA
17.1.1.3.MEXICO
17.1.2EUROPE
17.1.2.1.GERMANY
17.1.2.2.FRANCE
17.1.2.3.U.K.
17.1.2.4.HUNGARY
17.1.2.5.LITHUANIA
17.1.2.6.AUSTRIA
17.1.2.7.IRELAND
17.1.2.8.NORWAY
17.1.2.9.POLAND
17.1.2.10.ITALY
17.1.2.11.SPAIN
17.1.2.12.RUSSIA
17.1.2.13.TURKEY
17.1.2.14.NETHERLANDS
17.1.2.15.SWITZERLAND
17.1.2.16.REST OF EUROPE
17.1.3ASIA-PACIFIC
17.1.3.1.JAPAN
17.1.3.2.CHINA
17.1.3.3.SOUTH KOREA
17.1.3.4.INDIA
17.1.3.5.AUSTRALIA
17.1.3.6.SINGAPORE
17.1.3.7.THAILAND
17.1.3.8.MALAYSIA
17.1.3.9.INDONESIA
17.1.3.10.PHILIPPINES
17.1.3.11.VIETNAM
17.1.3.12.REST OF ASIA-PACIFIC
17.1.4SOUTH AMERICA
17.1.4.1.BRAZIL
17.1.4.2.ARGENTINA
17.1.4.3.PERU
17.1.4.4.REST OF SOUTH AMERICA
17.1.5MIDDLE EAST AND AFRICA
17.1.5.1.SOUTH AFRICA
17.1.5.2.SAUDI ARABIA
17.1.5.3.UAE
17.1.5.4.EGYPT
17.1.5.5.KUWAIT
17.1.5.6.ISRAEL
17.1.5.7.REST OF MIDDLE EAST AND AFRICA
17.1.6KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
18.GLOBAL SMART INSULIN PEN MARKET, SWOT AND DBMR ANALYSIS
19.GLOBAL SMART INSULIN PEN MARKET, COMPANY LANDSCAPE
19.1COMPANY SHARE ANALYSIS: GLOBAL
19.2COMPANY SHARE ANALYSIS: NORTH AMERICA
19.3COMPANY SHARE ANALYSIS: EUROPE
19.4COMPANY SHARE ANALYSIS: ASIA-PACIFIC
19.5MERGERS & ACQUISITIONS
19.6NEW PRODUCT DEVELOPMENT & APPROVALS
19.7EXPANSIONS
19.8REGULATORY CHANGES
19.9PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
20.GLOBAL SMART INSULIN PEN MARKET, COMPANY PROFILE
20.1PENDIQ
20.1.1COMPANY OVERVIEW
20.1.2REVENUE ANALYSIS
20.1.3GEOGRAPHIC PRESENCE
20.1.4PRODUCT PORTFOLIO
20.1.5RECENT DEVELOPMENTS
20.2NOVO NORDISK
20.2.1COMPANY OVERVIEW
20.2.2REVENUE ANALYSIS
20.2.3GEOGRAPHIC PRESENCE
20.2.4PRODUCT PORTFOLIO
20.2.5RECENT DEVELOPMENTS
20.3MEDTRONIC
20.3.1COMPANY OVERVIEW
20.3.2REVENUE ANALYSIS
20.3.3GEOGRAPHIC PRESENCE
20.3.4PRODUCT PORTFOLIO
20.3.5RECENT DEVELOPMENTS
20.4US MED
20.4.1COMPANY OVERVIEW
20.4.2REVENUE ANALYSIS
20.4.3GEOGRAPHIC PRESENCE
20.4.4PRODUCT PORTFOLIO
20.4.5RECENT DEVELOPMENTS
20.5INSULCLOUD S.L.
20.5.1COMPANY OVERVIEW
20.5.2REVENUE ANALYSIS
20.5.3GEOGRAPHIC PRESENCE
20.5.4PRODUCT PORTFOLIO
20.5.5RECENT DEVELOPMENTS
20.6TIMESULIN (PATIENTS PENDING LTD)
20.6.1COMPANY OVERVIEW
20.6.2REVENUE ANALYSIS
20.6.3GEOGRAPHIC PRESENCE
20.6.4PRODUCT PORTFOLIO
20.6.5RECENT DEVELOPMENTS
20.7EMPERRA GMBH E-HEALTH TECHNOLOGIES
20.7.1COMPANY OVERVIEW
20.7.2REVENUE ANALYSIS
20.7.3GEOGRAPHIC PRESENCE
20.7.4PRODUCT PORTFOLIO
20.7.5RECENT DEVELOPMENTS
20.8YPSOMED
20.8.1COMPANY OVERVIEW
20.8.2REVENUE ANALYSIS
20.8.3GEOGRAPHIC PRESENCE
20.8.4PRODUCT PORTFOLIO
20.8.5RECENT DEVELOPMENTS
20.9BIGFOOT BIOMEDICAL, INC.
20.9.1COMPANY OVERVIEW
20.9.2REVENUE ANALYSIS
20.9.3GEOGRAPHIC PRESENCE
20.9.4PRODUCT PORTFOLIO
20.9.5RECENT DEVELOPMENTS
20.10BIOCORP
20.10.1COMPANY OVERVIEW
20.10.2REVENUE ANALYSIS
20.10.3GEOGRAPHIC PRESENCE
20.10.4PRODUCT PORTFOLIO
20.10.5RECENT DEVELOPMENTS
20.11JIANGSU DELFU MEDICAL DEVICE CO.,LTD
20.11.1COMPANY OVERVIEW
20.11.2REVENUE ANALYSIS
20.11.3GEOGRAPHIC PRESENCE
20.11.4PRODUCT PORTFOLIO
20.11.5RECENT DEVELOPMENTS
20.12ELI LILLY AND COMPANY
20.12.1COMPANY OVERVIEW
20.12.2REVENUE ANALYSIS
20.12.3GEOGRAPHIC PRESENCE
20.12.4PRODUCT PORTFOLIO
20.12.5RECENT DEVELOPMENTS
20.13BIOCORP
20.13.1COMPANY OVERVIEW
20.13.2REVENUE ANALYSIS
20.13.3GEOGRAPHIC PRESENCE
20.13.4PRODUCT PORTFOLIO
20.13.5RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
21.RELATED REPORTS
22.CONCLUSION
23.QUESTIONNAIRE
24.ABOUT DATA BRIDGE MARKET RESEARCH

Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.